Orchid gains on successfully completing Phase-I study of OCID 2987

03 Jan 2012 Evaluate

Orchid Chemicals & Pharmaceuticals is currently trading at Rs 135.85, up by 0.90 points or 0.67% from its previous closing of Rs 134.95 on the BSE.

The scrip opened at Rs 136.00 and has touched a high and low of Rs 137.40 and Rs 135.30 respectively. So far 213004 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 324.65 on 04-Apr-2011 and a 52 week low of Rs 112.25 on 19-Dec-2011.

Last one week high and low of the scrip stood at Rs 139.80 and Rs 124.30 respectively. The current market cap of the company is Rs 960.13 crore.

The promoters holding in the company stood at 29.83% while Institutions and Non-Institutions held 18.30% and 47.29% respectively. 

Orchid Chemicals & Pharmaceuticals has successfully completed in Europe a Phase-I trial of its orally administered phosphodiesterase 4 inhibitor (PDE4) molecule OCID 2987 positioned for the treatment of inflammatory disorders including chronic obstructive pulmonary disease (COPD).

The Phase-I study was conducted to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic effects of OCID 2987 at escalating single or repeated doses on healthy male volunteers. OCID 2987 was well tolerated up to the highest doses administered in both single and repeat dose studies and did not demonstrate a potential for nausea/emesis, a common unacceptable side-effect with most PDE4 inhibitors. Also, there were no serious adverse events or any cardiac safety concerns reported in the study.

Orchid's drug discovery efforts are conducted through its wholly-owned subsidiary, Orchid Research Laboratories.

Orchid is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit.

Orchid Pharma Share Price

761.60 -9.00 (-1.17%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×